CARGO Therapeutics, Inc. Contracts & Agreements

Amended and Restated Non-Employee Director Compensation Program (Filed With SEC on August 12, 2024)

Second Amendment to Sublease Agreement, dated June 21, 2024, by and between BigHat Biosciences, Inc. and CARGO Therapeutics, Inc. (f/k/a Syncopation Life Sciences, Inc.) (Filed With SEC on August 12, 2024)

Sublease Agreement, dated July 1, 2024, by and between CARGO Therapeutics, Inc. and Vaxcyte, Inc (Filed With SEC on July 8, 2024)

Form of Securities Purchase Agreement, dated May 28, 2024, by and among the Company and the Purchasers (Filed With SEC on May 28, 2024)

Exchange Agreement, dated January 12, 2024, by and between CARGO Therapeutics, Inc. and the Investors listed therein, and Form of Warrant (Filed With SEC on May 14, 2024)

Amendment No. 1 to License and Supply Agreement, dated June 24, 2022, by and between CARGO Therapeutics, Inc. and Oxford Biomedica (UK) Limited (Filed With SEC on May 14, 2024)

Lease Agreement dated December 11, 2023 between ARE-San Francisco No. 63, LLC and CARGO Therapeutics, Inc (Filed With SEC on March 21, 2024)

Lease Agreement dated December 11, 2023 between ARE-San Francisco No. 63, LLC and CARGO Therapeutics, Inc (Filed With SEC on December 13, 2023)

CARGO Therapeutics, Inc. 2021 Stock Option and Grant Plan and forms of option agreements thereunder (Filed With SEC on November 6, 2023)

Patent License Agreement, dated February 24, 2023, by and between the Registrant and the National Cancer Institute (Filed With SEC on November 6, 2023)

Amendment No. 5 to CARGO Therapeutics, Inc. 2021 Stock Option and Grant Plan (Filed With SEC on November 6, 2023)

Form Agreements under the CARGO Therapeutics, Inc. 2021 Stock Option and Grant Plan (Filed With SEC on November 6, 2023)

2023 Incentive Award Plan (Filed With SEC on November 6, 2023)

Form of Stock Option Grant Notice and Stock Option Agreement under the 2023 Incentive Award Plan (Filed With SEC on November 6, 2023)

Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2023 Incentive Award Plan (Filed With SEC on November 6, 2023)

Employee Stock Purchase Plan (Filed With SEC on November 6, 2023)

Employment Agreement by and between the Registrant and Gina Chapman (Filed With SEC on November 6, 2023)

Employment Agreement by and between the Registrant and Anup Radhakrishnan (Filed With SEC on November 6, 2023)

Employment Agreement by and between the Registrant and Shishir Gadam (Filed With SEC on November 6, 2023)

Form of Indemnification and Advancement Agreement for directors and officers (Filed With SEC on November 6, 2023)

Sublease Agreement, dated November 4, 2021, by and between BigHat Biosciences, Inc. and the Registrant (f/k/a Syncopation Life Sciences, Inc.) (Filed With SEC on November 6, 2023)

First Amendment to Sublease Agreement, dated August 17, 2022, by and between BigHat Biosciences, Inc. and the Registrant (f/k/a Syncopation Life Sciences, Inc.) (Filed With SEC on November 6, 2023)

Employment Agreement by and between the Registrant and Ginna Laport (Filed With SEC on November 6, 2023)

Non-Employee Director Compensation Program (Filed With SEC on November 6, 2023)

Patent License Agreement, dated March 16, 2022, by and between the Registrant and the National Cancer Institute (Filed With SEC on November 6, 2023)

License and Supply Agreement, dated June 24, 2022, by and between the Registrant and Oxford Biomedica (UK) Limited (Filed With SEC on November 6, 2023)

Amendment No. 1 to Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University (Filed With SEC on November 6, 2023)

Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University (Filed With SEC on November 6, 2023)

Amended and Restated Investors Rights Agreement, dated, February 9, 2023, by and among the Registrant and the investors listed therein (Filed With SEC on November 6, 2023)

Form of Common Stock Certificate (Filed With SEC on November 6, 2023)

Form of Underwriting Agreement (Filed With SEC on November 6, 2023)

License and Supply Agreement, dated June 24, 2022, by and between the Registrant and Oxford Biomedica (UK) Limited (Filed With SEC on November 1, 2023)

Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University (Filed With SEC on October 20, 2023)

Amended and Restated Investors Rights Agreement, dated, February 9, 2023, by and among the Registrant and the investors listed therein (Filed With SEC on October 20, 2023)

Amendment No. 1 to Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University (Filed With SEC on October 20, 2023)

Patent License Agreement, dated March 16, 2022, by and between the Registrant and the National Cancer Institute (Filed With SEC on October 20, 2023)

Patent License Agreement, dated February 24, 2023, by and between the Registrant and the National Cancer Institute (Filed With SEC on October 20, 2023)

CARGO Therapeutics, Inc. 2021 Stock Option and Grant Plan and forms of option agreements thereunder (Filed With SEC on October 20, 2023)

Amendment No. 5 to CARGO Therapeutics, Inc. 2021 Stock Option and Grant Plan (Filed With SEC on October 20, 2023)

Form Agreements under the CARGO Therapeutics, Inc. 2021 Stock Option and Grant Plan (Filed With SEC on October 20, 2023)

Employment Agreement by and between the Registrant and Gina Chapman (Filed With SEC on October 20, 2023)

Employment Agreement by and between the Registrant and Anup Radhakrishnan (Filed With SEC on October 20, 2023)

Employment Agreement by and between the Registrant and Shishir Gadam (Filed With SEC on October 20, 2023)

Form of Indemnification and Advancement Agreement for directors and officers (Filed With SEC on October 20, 2023)

Sublease Agreement, dated November 4, 2021, by and between BigHat Biosciences, Inc. and the Registrant (f/k/a Syncopation Life Sciences, Inc.) (Filed With SEC on October 20, 2023)

First Amendment to Sublease Agreement, dated August 17, 2022, by and between BigHat Biosciences, Inc. and the Registrant (f/k/a Syncopation Life Sciences, Inc.) (Filed With SEC on October 20, 2023)

Employment Agreement by and between the Registrant and Ginna Laport (Filed With SEC on October 20, 2023)

Category

Industry

Companies

Contracts

CARGO Therapeutics, Inc. Contracts & Agreements